List of Salonpas drug patents
Salonpas is owned by Hisamitsu Pharm Co.
Salonpas contains Menthol; Methyl Salicylate.
Salonpas has a total of 2 drug patents out of which 0 drug patents have expired.
Salonpas was authorised for market use on 20 February, 2008.
Salonpas is available in patch;topical dosage forms.
The generics of Salonpas are possible to be released after 03 January, 2030.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9233184 | HISAMITSU PHARM CO | Adhesive preparation |
Aug, 2027
(4 years from now) | |
| US8809615 | HISAMITSU PHARM CO | Adhesive preparation |
Jan, 2030
(6 years from now) | |
Drugs and Companies using MENTHOL; METHYL SALICYLATE ingredient
Market Authorisation Date: 20 February, 2008
Treatment: NA
Dosage: PATCH;TOPICAL
SALONPAS family patents
4
United States
3
Japan
1
Taiwan, Province of China
1
Hungary
1
Korea, Republic of
1
New Zealand
1
Singapore
1
Australia
1
Malaysia
1
Canada
1
Russia
1
Mexico
1
Spain
1
China
1
Brazil
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic